indikations
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
21.04.2015
The ASCLEPION EFFECT: Spot on for perfect skin
With the concept „THE ASCLEPION EFFECT“ Asclepion Laser Technologies aims to communicate to the users the advatages of laser technology „Made in Germany“ and to increase the well being of […]
21.07.2015
Sublime and Sublative applications for comprehensive facial rejuvenation
Interview with Dermatologist Dr. Ines Verner* * Dr. Ines Verner is President of the Israel Society of Dermatologic Surgery and is owner of the Ines Verner Clinic of Dermatology and […]